BOSTON & CHICAGO--(BUSINESS WIRE)--Mitra Biotech, a cancer diagnostics company, today announced that a study validating its flagship platform CANScriptTM has been published in Nature Communications, an open access, multidisciplinary journal dedicated to publishing high-quality research in all areas of the biological, physical, chemical and Earth sciences. Papers published by the journal represent important advances of significance to specialists within each field. The article "Predicting clinical response to anti-cancer drugs using an ex vivo platform that captures tumor heterogeneity” was published in Nature Communications on February 27, 2015 and can be viewed at: http://ow.ly/JJPkm.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
